Reckitt Benckiser sees modest bounce following $7.1 billion market-cap wipeout
By Steve Goldstein
Reckitt Benckiser saw modest gains on Monday, following the share-price slide that erased some GBP5.6 billion ($7.1 billion) of market value.
Reckitt Benckiser shares (UK:RKT) rose 1.4% in afternoon trade, after a decline of nearly 15% on Friday, when an Illinois jury ordered its Mead Johnson unit to pay $60 million in compensation for the death of a premature baby who was fed Enfamil. Reckitt said it will appeal the decision.
Related: Here's what families need to know after a landmark $60 million verdict in baby-formula suit
There are more than 400 lawsuits against Mead Johnson and Abbott pending in federal court in Chicago, according to Reuters. Analysts at Barclays said that number may grow, but plaintiff numbers would not likely exceed "a few thousand plaintiffs settling in the high hundreds of thousands of dollars a case."
Analysts at RBC Capital Markets led by James Edwardes Jones said a call with company executives was reassuring.
"Reckitt believes there were errors in the trial and that there is no evidence to support a causal relationship between its products and [necrotizing enterocolitis]. Indeed it is the case that breast milk offers the lowest incidence rates of NEC in pre-term infants, but when it (and donor breast milk) is unavailable, infant milk products are the next best thing," they said.
Analysts at Deutsche Bank said the maximum liability would be between GBP1.5 billion and GBP3.3 billion.
-Steve Goldstein
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
03-18-24 1053ET
Copyright (c) 2024 Dow Jones & Company, Inc.-
These Stocks Are (Still) Powering the Bull Market
-
5 Undervalued Energy Stocks to Play the AI Data Center Demand Boom
-
After Earnings, Is Lowe’s Stock a Buy, Sell, or Fairly Valued?
-
5 Stocks With the Largest Fair Value Estimate Cuts After Q1 Earnings
-
10 Stocks With the Largest Fair Value Estimate Increases After Q1 Earnings
-
Markets Brief: Inflation Back in the Spotlight
-
AI Is Booming, but Consumer Spending Is Slowing. Which Will Prevail in the Stock Market?
-
What’s Happening In the Markets This Week
-
3 Dividend Stocks for June 2024
-
After Earnings, Is Alibaba Stock a Buy, Sell, or Fairly Valued?
-
MongoDB Earnings: Slashing Valuation as Execution and Macro to Blame for Lower Guidance
-
Marvell Earnings: We Raise Our Medium-Term AI Forecast and Bring Our Valuation Up to $75
-
Zscaler Earnings: Impressive Traction in Emerging Products Drives Sales Growth for the Quarter
-
Dell Earnings: Raising Valuation on Strong AI, but the Stock Remains Severely Overvalued
-
After Earnings, Is Nvidia Stock a Buy, Sell, or Fairly Valued?
-
The 10 Best Companies to Invest in Now